 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on May 26, 2023 |
| Title |
Identification of miR-151a as a universal endogenous control for exosome cargo normalization in human cancer |
| Organism |
Homo sapiens |
| Experiment type |
Non-coding RNA profiling by high throughput sequencing
|
| Summary |
The exosomal particles in the blood of cancer patients possess many times more tumor markers than free circulating. Among these elements, miRNAs have great biomedical relevance due to their stability and feasible detection. However, there is not available in the market any reliable endogenous control for the exosomal compartment, nor specific for the miRNA content, preventing the obtainment of standardization measures in cancer liquid-biopsy. In this study, we firstly identified three miRNAs out of a panel of nine potential normalizers that arised from an integrative analysis comparing the global miRNA exosomal profile by miRNA-seq of six lung and ovarian human cancer cell lines under different chemotherapy conditions. Their value as normalizers were also tested in 14 additional human cancer cell lines from different tumor types and after radiotherapy and an alternative chemotherapy treatment. Its translational validation comprised 124 prospective samples, 70 plasma from NSCLC patients, 12 from glioblastoma patients, 10 healthy donors and 16 paired samples from plasma and ascites fluid from ovarian cancer patients. The variability and normalizing properties were tested in comparison with the tissue-origin gold standard miR-16. Our results indicate that miR-151a is constantly represented in the exosomal content with minimal variability compared with miR16 independently of many conditions tested, providing for the first time a universal normalizer for the exosomal compartment that will impact the use of liquid biopsy.
|
| |
|
| Overall design |
miRNA-seq from paired cisplatin-sensitive/resistant Cell line-derived exosomes was used to analyze small RNA expression profiling
|
| |
|
| Contributor(s) |
Jiménez J, Burdiel M, Rodríguez-Antolín C, Pernía O, Rosas-Alonso R, Sastre-Perona A, Colmenarejo J, Garcia-Guede A, Rodríguez-Jiménez C, Diestro MD, Martínez-Marín V, Higueras O, Cruz P, Losantos-García I, de Castro J, Ibáñez de Cáceres I |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
May 26, 2022 |
| Last update date |
May 26, 2023 |
| Contact name |
Carlos Rodriguez Antolin |
| Organization name |
Hospital La Paz Institute for Health Research
|
| Department |
Genetics
|
| Lab |
Cancer Epigenetics
|
| Street address |
Paseo de la Castellana
|
| City |
Madrid |
| ZIP/Postal code |
28046 |
| Country |
Spain |
| |
|
| Platforms (1) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
| Samples (6)
|
|
| Relations |
| BioProject |
PRJNA842752 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE204944_tpm_counts.txt.gz |
15.5 Kb |
(ftp)(http) |
TXT |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data are available on Series record |
|
|
|
|
 |
Less...
More...